Literature DB >> 14684662

Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndrome.

Akira Shimada, Gang Xu, Tsutomu Toki, Hirokazu Kimura, Yasuhide Hayashi, Etsuro Ito.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14684662     DOI: 10.1182/blood-2003-09-3219

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Myeloid leukemia in Down syndrome.

Authors:  Irum Khan; Sébastien Malinge; John Crispino
Journal:  Crit Rev Oncog       Date:  2011

Review 2.  The biology of pediatric acute megakaryoblastic leukemia.

Authors:  Tanja A Gruber; James R Downing
Journal:  Blood       Date:  2015-07-17       Impact factor: 22.113

3.  Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome.

Authors:  Hirokazu Kanegane; Sayaka Watanabe; Keiko Nomura; Gang Xu; Etsuro Ito; Toshio Miyawaki
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

Review 4.  Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology.

Authors:  Ana C Xavier; Yubin Ge; Jeffrey W Taub
Journal:  J Mol Diagn       Date:  2009-09       Impact factor: 5.568

5.  Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome.

Authors:  Diane C Cabelof; Hiral V Patel; Qing Chen; Holly van Remmen; Larry H Matherly; Yubin Ge; Jeffrey W Taub
Journal:  Blood       Date:  2009-07-24       Impact factor: 22.113

6.  Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.

Authors:  Shiori Matsuo; Yoko Nishinaka-Arai; Yasuhiro Kazuki; Mitsuo Oshimura; Tatsutoshi Nakahata; Akira Niwa; Megumu K Saito
Journal:  PLoS One       Date:  2021-03-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.